ANN ARBOR, Mich.
Nov. 7, 2011
/PRNewswire/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), announced today that it has executed an agreement with F&F Foods of
, to provide commercial-scale manufacturing of
, the Company's oral zinc lozenge to reduce the duration and symptoms of the common cold. Adeona is planning to commercialize
, a lozenge that contains 13.3 mg of zinc acetate, based on formulations clinically tested by
Ananda S. Prasad
, M.D., Ph.D., a Distinguished Professor of Internal Medicine at
Wayne State University
School of Medicine and an Adeona Scientific Advisory Board member.
is intended to be a natural, safe and effective homeopathic over-the-counter (OTC) medicine for the common cold.
, Adeona obtained exclusive access to statistically significant clinical data from two separate studies conducted by Dr. Prasad that evaluated the effectiveness of zinc acetate lozenges on the reduction of the duration and the symptoms of the common cold. Based upon findings from Dr. Prasad's two clinical studies[i],[ii] and his expertise as a pioneer in the field of zinc, he believes that many of the zinc preparations currently available on the market include a sub-optimal formulation and/or dose of zinc, and also include flavors and binders that diminish the effectiveness of zinc treatment for the common cold. In a
February 15, 2011
New York Times
article that referred to the recently published Cochrane Review of zinc for the common cold, Dr. Prasad was quoted as saying, "The public is confused because people have used the wrong dose, they have used the wrong sort of zinc or they have not started the treatment within 24 hours of onset."
"I am so excited to make
commercially available for adults suffering from the symptoms of the common cold. When I notice cold symptoms coming on, it is the worst feeling and
has the potential to cut the duration and the severity of symptoms of the common cold in half if you start taking it right away," stated
James S. Kuo
, M.D., M.B.A., Adeona's Chief Executive Officer. "That is why executing this agreement with F&F Foods for the manufacturing of
is so important – it brings us one step for closer to commercialization."